Pfizer PBC 125 (Ibrance 125 mg)
Generic Name: palbociclib
Pill imprint Pfizer PBC 125 has been identified as Ibrance 125 mg.
Ibrance is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class multikinase inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Ibrance (palbociclib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.